-
Highly Processed Diets Tied to Heart Disease, Earlier Death
drugs
May 31, 2019
People who get many of their meals from packages may have heightened risks of heart disease, stroke and premature death, two large studies suggest.
-
Mirikizimab moved to Phase III after positive trial findings
europeanpharmaceuticalreview
May 24, 2019
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
-
Q Fever? A Bigger Threat to Humans Than Thought
drugs
May 22, 2019
You've probably never heard of Q fever, but the bacterial disease may be sickening -- and killing -- more Americans than once believed, a new study suggests.
-
Skyhawk, Takeda to Develop Neurological Disease Targets
contractpharma
May 16, 2019
Skyhawk will use its SkySTAR platform to discover and develop small molecule treatments.
-
Researchers block protein that plays a key role in Alzheimer's disease
worldpharmanews
May 16, 2019
Researchers block protein that plays a key role in Alzheimer's disease.
-
Researchers block protein that plays a key role in Alzheimer's disease
worldpharmanews
May 16, 2019
Researchers block protein that plays a key role in Alzheimer's disease.
-
AHA News: Why Are Women With Diabetes at Greater Risk for Poor Heart Health?
drugs
May 15, 2019
Diabetes can be a risk factor for heart disease – but for women, the condition can lead to worse outcomes than for men.
-
Novartis to buy Takeda’s dry eye drug Xiidra for $3.4bn
pharmaceutical-business-review
May 14, 2019
Novartis has agreed to acquire dry eye drug Xiidra (lifitegrast ophthalmic solution) 5% from Takeda for $3.4bn.
-
CDC: U.S. Measles Cases in 2019 Reach 839
drugs
May 14, 2019
The number of reported measles cases in the United States climbed to 839 as of last week, the highest yearly total in 25 years, the U.S. Centers for Disease Control and Prevention said Monday.
-
Researchers define Alzheimer's-like brain disorder
worldpharmanews
May 10, 2019
Researchers define Alzheimer's-like brain disorder.